Leadership Overview
Crinetics Pharmaceuticals has 6 executives leading key functions including finance, human resources, operations, legal, and medical affairs.
Driven by patient needs, Crinetics Pharmaceuticals develops essential therapies for endocrine diseases, aiming for effective disease control and simplified treatment regimens, while building investor value by addressing critical market gaps.
Driven by patient needs, Crinetics Pharmaceuticals develops essential therapies for endocrine diseases, aiming for effective disease control and simplified treatment regimens, while building investor value by addressing critical market gaps.
Leadership Roles at Crinetics Pharmaceuticals
Tobin Schilke - Chief Financial Officer
Tobin Schilke, the Chief Financial Officer at Crinetics Pharmaceuticals, directs all financial operations and strategic fiscal planning. Schilke oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and resource allocation to support the company's development of novel therapies for endocrine diseases. This leadership role involves managing investor relations and capital management, directly contributing to the company's objective of filling real market needs and building value for stakeholders. By optimizing financial strategies, Tobin Schilke ensures that Crinetics Pharmaceuticals maintains a strong financial foundation to advance its mission of providing effective disease control and simplifying lives for patients. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding the company's assets and financial integrity as it navigates the complex pharmaceutical landscape.
Niccole Le - Chief of Staff To the Chief Operating Officer and Head of Alliance Management
Niccole Le, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management at Crinetics Pharmaceuticals, drives strategic initiatives and operational alignment across key functions. Le orchestrates critical projects, enhances communication flows between the COO and other departments, and manages the company's strategic partnerships and alliances. This dual role ensures that operational efficiency supports the company's growth objectives and that alliance management activities are seamlessly integrated with overall business strategy. By fostering strong relationships with external partners and internal teams, Niccole Le advances Crinetics Pharmaceuticals' mission to develop much-needed therapies. The Chief of Staff's focus on operational excellence and strategic collaboration is essential for navigating market complexities and delivering value to patients and investors.
Natalie Berwald - Executive Assistant To the Chief Human Resources Officer
Natalie Berwald, the Executive Assistant To the Chief Human Resources Officer at Crinetics Pharmaceuticals, provides critical administrative and operational support to the HR leadership. Berwald manages complex scheduling, coordinates executive communications, and facilitates the smooth functioning of the human resources department, ensuring efficient support for employee-related initiatives. This role is integral to maintaining organizational effectiveness and supporting the strategic objectives of the Chief Human Resources Officer. By managing key administrative tasks, Natalie Berwald enables the HR team to focus on developing and implementing programs that support Crinetics Pharmaceuticals' mission and its people. The executive assistant's contributions are vital for operational continuity and the effective execution of HR strategies within the company.
Rafael Marino - Affairs Operations Senior Director, Medical & Chief of Staff
Rafael Marino, the Affairs Operations Senior Director, Medical & Chief of Staff at Crinetics Pharmaceuticals, spearheads critical medical operations and provides strategic support to executive leadership. Marino oversees the execution of medical affairs strategies, ensuring alignment with the company's mission to develop effective therapies for endocrine diseases. This role involves managing operational aspects of medical programs and acting as a key liaison between medical teams and other departments, including serving as Chief of Staff. By driving operational efficiency within medical affairs, Rafael Marino directly supports the company's commitment to solving real problems for patients and healthcare practitioners. The focus on seamless operations and strategic coordination is vital for advancing the development and delivery of innovative treatments.
Adriana Cabre - Chief Human Resources Officer
Adriana Cabre, the Chief Human Resources Officer at Crinetics Pharmaceuticals, directs all human capital strategies and organizational development initiatives. Cabre is responsible for cultivating a high-performance culture, attracting and retaining top talent, and ensuring that HR programs align with the company's mission to develop life-changing therapies for endocrine diseases. This leadership position involves overseeing employee relations, compensation and benefits, and talent management to support the company's growth and operational objectives. By fostering a supportive and dynamic work environment, Adriana Cabre ensures that Crinetics Pharmaceuticals has the skilled workforce necessary to innovate and succeed. The Chief Human Resources Officer's strategic approach to people management is fundamental to the company's long-term success and its ability to meet market needs.
Garlan Adams - Chief Legal Officer
Garlan Adams, the Chief Legal Officer at Crinetics Pharmaceuticals, provides comprehensive legal counsel and oversees all legal affairs for the organization. Adams ensures compliance with regulatory requirements, manages intellectual property, and advises on corporate governance and strategic transactions, safeguarding the company's interests. This role is crucial for navigating the complex legal landscape of the pharmaceutical industry and supporting the development of therapies for endocrine diseases. By providing expert legal guidance, Garlan Adams enables Crinetics Pharmaceuticals to operate ethically and effectively, mitigating risks and fostering a stable environment for innovation. The Chief Legal Officer's strategic oversight is essential for protecting the company's assets and advancing its mission to provide effective disease control.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership MR
BG
BK
JS
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence worldwide. The companys product candidates focus on treating opioid use disorder, alcohol use disorder, overdose rescue, and CNS disorders/schizophrenia. It markets and promotes SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company was incorporated in 2014 and is headquartered in Richmond,...
Company Leadership
JB
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan.
Company Leadership TM
CP
GP
Dong-A Socio Group is a professional healthcare organization that focuses on fulfilling social responsibility through various sectors including medical and digital healthcare, consumer products, logistics, IT services, and engineering. The company aims to enhance human health and well-being by providing specialized medical services, health functional foods, and integrated logistics solutions. With a commitment to innovation and consumer-oriented management, Dong-A Socio Group strives to create value and lead change in the industry. Their target clients include healthcare providers, consumers seeking health products, and businesses requiring logistics and IT solutions.
Company Leadership HH
WK
SP
CK
Frequently Asked Questions Regarding Crinetics Pharmaceuticals Top Executives and Leadership Team
Unlock more people and company data
